User profiles for Frank DeFalco
Frank J DeFalcoJanssen Research & Development Verified email at its.jnj.com Cited by 1505 |
Characterizing treatment pathways at scale using the OHDSI network
…, MJ Schuemie, FJ DeFalco… - Proceedings of the …, 2016 - National Acad Sciences
Observational research promises to complement experimental research by providing large,
diverse populations that would be infeasible for an experiment. Observational research can …
diverse populations that would be infeasible for an experiment. Observational research can …
Feasibility and utility of applications of the common data model to multiple, disparate observational health databases
Objectives To evaluate the utility of applying the Observational Medical Outcomes Partnership
(OMOP) Common Data Model (CDM) across multiple observational databases within an …
(OMOP) Common Data Model (CDM) across multiple observational databases within an …
Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with …
Aims Sodium glucose co‐transporter 2 inhibitors (SGLT2i) are indicated for treatment of type
2 diabetes mellitus (T2DM); some SGLT2i have reported cardiovascular benefit, and some …
2 diabetes mellitus (T2DM); some SGLT2i have reported cardiovascular benefit, and some …
Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium‐glucose co‐transporter‐2 inhibitors in the USA: a retrospective cohort …
Z Yuan, FJ DeFalco, PB Ryan… - Diabetes, Obesity …, 2018 - Wiley Online Library
Aims To examine the incidence of amputation in patients with type 2 diabetes mellitus (T2DM)
treated with sodium glucose co‐transporter 2 (SGLT2) inhibitors overall, and canagliflozin …
treated with sodium glucose co‐transporter 2 (SGLT2) inhibitors overall, and canagliflozin …
Increasing trust in real-world evidence through evaluation of observational data quality
Objective Advances in standardization of observational healthcare data have enabled
methodological breakthroughs, rapid global collaboration, and generation of real-world evidence …
methodological breakthroughs, rapid global collaboration, and generation of real-world evidence …
[HTML][HTML] Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
Comorbid conditions appear to be common among individuals hospitalised with coronavirus
disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the …
disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the …
[HTML][HTML] Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents
Y Wang, M Desai, PB Ryan, FJ DeFalco… - Diabetes research and …, 2017 - Elsevier
Aims To estimate and compare incidence of diabetes ketoacidosis (DKA) among patients
with type 2 diabetes who are newly treated with SGLT2 inhibitors (SGLT2i) versus non-SGLT2i …
with type 2 diabetes who are newly treated with SGLT2 inhibitors (SGLT2i) versus non-SGLT2i …
[HTML][HTML] Multisite evaluation of a data quality tool for patient-level clinical data sets
Methods: We describe a data quality analysis tool (called Achilles Heel) developed by the
Observational Health Data Sciences and Informatics Collaborative (OHDSI) and compare …
Observational Health Data Sciences and Informatics Collaborative (OHDSI) and compare …
Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co‐transporter 2 inhibitors versus other antihyperglycemic agents: An observational …
Purpose To compare the incidence of diabetic ketoacidosis (DKA) among patients with type
2 diabetes mellitus (T2DM) who were new users of sodium glucose co‐transporter 2 …
2 diabetes mellitus (T2DM) who were new users of sodium glucose co‐transporter 2 …
Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS
Purpose Routinely collected real world data (RWD) have great utility in aiding the novel
coronavirus disease (COVID-19) pandemic response. Here we present the international …
coronavirus disease (COVID-19) pandemic response. Here we present the international …